Presentations
Explore our most recent presentations below.
March 3rd, 2026
First-in-class radioligand therapy targeting uPAR
- the pan-tumor functional driver of invasion, angiogenesis, and metastasis
One target. One therapy. Pipeline-in-a-drug for aggressive solid tumors
Presented at the TD Cowen’s 46th Annual Health Care Conference in Boston
February 26th, 2026
Review - Annual Report 2025
Presented via HC Andersen Capital
View the presentation from the annual report 2025